BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 18286392)

  • 21. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parthenotes as a source of embryonic stem cells.
    Brevini TA; Gandolfi F
    Cell Prolif; 2008 Feb; 41 Suppl 1(Suppl 1):20-30. PubMed ID: 18181942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of pluripotent stem cells for regenerative medicine.
    Li K; Kong Y; Zhang M; Xie F; Liu P; Xu S
    Biochem Biophys Res Commun; 2016 Feb; 471(1):1-4. PubMed ID: 26851367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reprogramming cellular identity for regenerative medicine.
    Cherry AB; Daley GQ
    Cell; 2012 Mar; 148(6):1110-22. PubMed ID: 22424223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Very small embryonic-like cells in the mirror of regenerative medicine.
    Vojnits K; Yang L; Zhan M; Cox C; Li Y
    J Stem Cells; 2014; 9(1):1-16. PubMed ID: 25158086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification, characterization and biological significance of very small embryonic-like stem cells (VSELs) in regenerative medicine.
    Feng G; Cui J; Zheng Y; Han Z; Xu Y; Li Z
    Histol Histopathol; 2012 Jul; 27(7):827-33. PubMed ID: 22648539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical control of stem cell fate and developmental potential.
    Lyssiotis CA; Lairson LL; Boitano AE; Wurdak H; Zhu S; Schultz PG
    Angew Chem Int Ed Engl; 2011 Jan; 50(1):200-42. PubMed ID: 21184400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reprogramming Enhancers in Somatic Cell Nuclear Transfer, iPSC Technology, and Direct Conversion.
    Kwon D; Ji M; Lee S; Seo KW; Kang KS
    Stem Cell Rev Rep; 2017 Feb; 13(1):24-34. PubMed ID: 27817181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 'sweet' spot of cellular pluripotency: protein glycosylation in human pluripotent stem cells and its applications in regenerative medicine.
    Wang YC; Lin V; Loring JF; Peterson SE
    Expert Opin Biol Ther; 2015 May; 15(5):679-87. PubMed ID: 25736263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Totipotency, pluripotency and nuclear reprogramming.
    Mitalipov S; Wolf D
    Adv Biochem Eng Biotechnol; 2009; 114():185-99. PubMed ID: 19343304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine.
    Kuçi S; Kuçi Z; Latifi-Pupovci H; Niethammer D; Handgretinger R; Schumm M; Bruchelt G; Bader P; Klingebiel T
    Curr Stem Cell Res Ther; 2009 May; 4(2):107-17. PubMed ID: 19442195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in culture and manipulation of human pluripotent stem cells.
    Qian X; Villa-Diaz LG; Krebsbach PH
    J Dent Res; 2013 Nov; 92(11):956-62. PubMed ID: 23934156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative sources of pluripotent stem cells: altered nuclear transfer.
    Condic ML
    Cell Prolif; 2008 Feb; 41 Suppl 1(Suppl 1):7-19. PubMed ID: 18181941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dive into the stem cells world.
    Fagoonee S; Pellicano R; Altruda F
    Panminerva Med; 2009 Mar; 51(1):1-3. PubMed ID: 19352304
    [No Abstract]   [Full Text] [Related]  

  • 35. Introduction to stem cells and regenerative medicine.
    Kolios G; Moodley Y
    Respiration; 2013; 85(1):3-10. PubMed ID: 23257690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated transgenesis in rabbits: chimeric and nuclear transfer animals.
    Zakhartchenko V; Flisikowska T; Li S; Richter T; Wieland H; Durkovic M; Rottmann O; Kessler B; Gungor T; Brem G; Kind A; Wolf E; Schnieke A
    Biol Reprod; 2011 Feb; 84(2):229-37. PubMed ID: 20944083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Progress in the derivation, culture of human embryonic stem cells].
    Xu CM; Huang HF
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 37(1):103-7. PubMed ID: 18275129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional Role of Circular RNA in Regenerative Medicine.
    Cao RY; Dai Q; Li Q; Yang J
    Adv Exp Med Biol; 2018; 1087():299-308. PubMed ID: 30259376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. iPS cells--alternative pluripotent cells to embryo stem cells.
    Pei X
    Sci China Life Sci; 2010 Jan; 53(1):154-156. PubMed ID: 20596969
    [No Abstract]   [Full Text] [Related]  

  • 40. [Research development of amniotic fluid-derived stem cells in regenerative medicine].
    Li C; Li W; Liu H; Wang J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Oct; 27(10):1262-6. PubMed ID: 24397143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.